Despite increasing understanding of the changes in gastrointestinal and central neuroendocrine signaling following gastric bypass surgery (GBP) in morbidly obese patients, the mechanisms underlying weight loss and weight loss maintenance are not completely understood. Changes in energy expenditure are increasingly recognized as an important factor contributing to weight loss and metabolic effects in patients following GBP surgery. Experimental data regarding changes in energy balance following metabolic surgery in animal models suggest increased energy expenditure postoperatively as an important factor in the process of weight loss. However, the underlying neuroendocrine mechanisms are not well understood, and data regarding changes in energy expenditure in humans after GBP are inconsistent because of heterogenic patient populations and variable techniques. Nevertheless, a growing body of knowledge and understanding of the complex entero-neurohumoral interaction with its consequences in appetite, satiety and energy expenditure will help reveal the mechanisms of weight loss and weight loss maintenance following GBP surgery. Here we review how gastrointestinal hormones potentially regulate energy balance, and summarize current available experimental and clinical data on energy expenditure following obesity surgery.
Introduction
The worldwide obesity epidemic has increased significantly and is associated with increased morbidity and mortality rates. 1 The personal, social and economic consequences can be devastating. 2, 3 Until now, non-surgical interventions are of limited efficacy, 4 and the most effective therapeutic option currently available to obtain significant and maintained weight loss with a proven mortality benefit is obesity surgery. 5, 6 The numbers of such procedures being performed worldwide have increased sharply, 7 with the Roux-en-Y gastric bypass (gastric bypass (GBP)) currently considered as the gold-standard operative treatment for morbid obesity. 7 Against this background, it is important to understand the mechanisms by which GBP induces and sustains weight loss. Until recently, it was common belief that weight loss after GBP was due to mechanical restriction and malabsorption, 8 but there is a growing appreciation that other mechanisms have a role, including reduced hunger, 9 increased satiety, 9 altered taste [10] [11] [12] and reduced preference for foods with a high fat and sugar content. 13 One of the proposed mechanisms for reduced food intake after bypass surgery is that a secretory stimulus to the distal L cells of the ileum is produced, resulting in an increased level of gastrointestinal satiety hormones such as peptide YY (PYY) and peptides of the enteroglucagon family including glucagon-like peptide 1 (GLP-1) and oxyntomodulin. [14] [15] [16] These hormones are thought to stimulate anorectic pathways in the hypothalamus and brainstem leading to reduction of food intake via the so-called gut-brain axis. 17 The hypothalamus contains a number of nuclei, including the arcuate nucleus (ARC), paraventricular nucleus, ventromedial nucleus and the dorsomedial nucleus, all of which are interconnected by energy homeostasis-regulating circuits. 18, 19 The ARC receives and functions on circulating appetite signals including the modulated release of several key amino-acid neurotransmitters. 18, 19 The neurons in the medial ARC coexpress neuropeptide Y (NPY) and agoutirelated peptide, which stimulate food intake and weight gain by increasing appetite. 18, 19 By contrast, the neurons in the lateral ARC coexpress proopiomelanocortin (also known as corticotropin-lipotropin) and cocaine-and amphetamineregulated transcript, which both promote weight loss by decreasing appetite. 20, 21 Both the ARC and the brainstem are ideally positioned to interact with circulating humoral factors and to receive signals from the periphery. 22, 23 Thus, gut hormones may function directly in the brain after being released into the circulation and signaling through circumventricular organs. Alternatively, gut hormones may also mediate their effects via vagal afferents that project to these brain areas and influence them indirectly. 18, 19 In addition to contributing to postprandial satiety, some of these gastrointestinal hormones have also been shown to influence energy expenditure. 24 Guo et al. 25 recently demonstrated a negative correlation between circulating PYY levels and 15-h resting metabolic rate, as well as 24-h respiratory quotient, whereas peak PYY concentrations were negatively associated with changes in body weight. Furthermore, circulating postprandial PYY levels have been found to correlate with postprandial energy expenditure and the thermic effect of food. 26 Finally, dietinduced obese mice treated with PYY exhibited reduced food intake and fat mass with relative preservation of the body-mass-specific metabolic rate, despite their lower energy intake. 27 Although oxyntomodulin has been shown to augment core temperature and heart rate in rodents 28, 29 and to increase energy expenditure and voluntary physical activity levels in humans, 30 there appears to be no indication that GLP-1 might influence energy expenditure. Other candidate hormones with a potential influence on energy expenditure include pancreatic polypeptide, 31 amylin 32, 33 and ghrelin. 34 
Experimental data
Gastric bypass surgery in rats has been proven to be a valid model of human metabolic surgery. 35, 36 The body weight loss after GBP in rats is not entirely due to reduced food intake, as sham-operated rats that receive the same amount of food as GBP rats (pair-fed controls) still weigh more than GBP rats. 15 This observation has raised the possibility of enhanced energy expenditure following bypass surgery. 15 We therefore tested the hypothesis that energy expenditure would be higher after bypass surgery and found that GBP rats have a higher total energy expenditure when compared with ad libitum fed and body-weight-matched sham controls. 35 The increased energy expenditure did not correlate with differences in activity and/or body temperature, and other explanations such as malabsorption and inflammation were excluded. 35 Differences in energy expenditure were mainly because of changes during the light phase when physical activity is typically low. 35 As GBP rats showed a greater cumulative increase in total energy expenditure after a 5-g test meal compared with the control groups, we suggested that differences in diet-induced thermogenesis may have a role. 35 Furthermore, the postoperative increase in energy expenditure potentially represents a higher energy requirement, as the small intestine showed significant morphometric changes with a 72% increase of total small bowel weight postoperatively. 35 The gut is metabolically very active and gut hypertrophy may hence explain a higher energy requirement that contributes to body weight loss. 9, 37, 38 These findings are in line with previous reports demonstrating a reduced body weight without decreased food intake or malabsorption, but increased energy expenditure after GBP in rats. 39, 40 Furthermore, Stylopoulos et al. 41 described a 19% increase in total and a 31% increase in resting energy expenditure in rats after GBP operation. The authors concluded that these effects, along with a 17% decrease in food intake and a 4% decrease in nutrient absorption, account for the normalization of body weight after GBP. 41 The same authors also recorded energy expenditure measurements in rat models of other bariatric procedures (sleeve gastrectomy and gastric banding) in which the only alteration is the reduction of stomach size, but no significant effect on energy expenditure was found. 41 Fasting and body weight reduction usually leads to a downregulation of energy expenditure as a physiological compensatory mechanism to oppose weight loss. These processes, also referred to as the 'starvation response,' are thought to be partly the result of decreased leptin levels, which usually counterbalance a decreased caloric intake and aim to conserve energy. 42 Paradoxically, GBP surgery in rats not only prevents the expected decrease in energy expenditure subsequent to body weight loss but also actually increases total energy expenditure. 35, 41 As GBP significantly rearranges the gastrointestinal anatomy, we and others have suggested that gastrointestinal and central neuroendocrine signaling contribute to the intriguing phenomenon of increased energy expenditure after GBP. 35, 41 Two potential mechanisms may have a role. First, GBP may reset and lower the leptin 'set point' at which a certain concentration of plasma leptin is perceived by the hypothalamus as a state of energy insufficiency. 43 In that case, decreased leptin levels would not be perceived as a state of energy insufficiency in GBP rats, and, consequently, compensatory mechanism including an increased food intake or decreased energy expenditure remain absent. However, it is not clear how the leptin set point may be reset. An increased leptin receptor expression in the rat hypothalamus after GBP may partly have a role, 40 but other changes including a higher affinity of these receptors may also account for these observations. 43 A second potential mechanism, the 'starvation response' opposing weight loss, usually triggered by lower leptin levels, is overridden by increased gut hormones such as PYY levels. In fact, GBP increases postprandial levels of PYY, oxyntomodulin and GLP-1, 14, 15, 44 which are satietyinducing gut hormones and hence favoring an anorectic state, facilitating body weight loss through modulation of neuronal circuits in the hypothalamus and brainstem. 15, 16 Moreover, a higher hypothalamic PYY expression has been described in GBP rats, suggesting an inhibition of the Hormones, energy balance and bariatric surgery M Bueter and CW le Roux neuropeptide Y/agouti-related protein neurons in the ARC and an activation of the proopiomelanocortin/cocaineamphetamine-regulated transcript neurons. 40 Accordingly, exogenous PYY has been shown to activate anorectic proopiomelanocortin-expressing neurons in the ARC, and to inhibit neuropeptide Y neurons leading to reduced food intake and body weight. 22, 23 Consequently, PYY has been suggested to have a role in the control of energy expenditure. 45 In conclusion, there is a growing body of evidence that weight loss after GBP engages physiological processes that effectively oppose the compensatory mechanisms of weight loss (starvation response), including a reduced appetite, 15, 16 increased satiety, 15, 16 as well as increased energy expenditure. 35, 41 The question whether these processes include the lowering of a hypothalamic leptin set point or whether a 'starvation response' is overridden by increased levels of gastrointestinal satiety hormones such as PYY, or whether both mechanisms take place, remains unclear and warrants further investigation.
Human studies
The increased levels of total energy expenditure in rats after GBP are in accordance with some, but not all, previous reports of energy expenditure in humans. De Castro et al. 46 measured resting energy expenditure in 21 women before and 3 months after GBP and found a significant reduction in absolute resting energy expenditure after surgery. The magnitude of decreased resting energy expenditure was proportional to the postoperative weight loss. In another study, Carrasco et al. 47 evaluated changes in resting energy expenditure in 31 morbidly obese patients, 6 months before and after GBP, and also found a significant reduction in resting energy expenditure. Unfortunately, the authors did not include a control group in their analysis. Das et al. 48 also examined changes in energy expenditure in 30 obese women and men and found that total and resting energy expenditure decreased by 25% on average after massive weight loss induced by GBP surgery. Changes in energy expenditure were predicted by loss of body tissue. The authors therefore concluded that there was no significant long-term change in energy efficiency that would independently promote weight regain. 48 Unfortunately, Das et al. 48 did not provide any details of their surgical GBP technique, and comparison with other studies is therefore difficult. In contrast, Flancbaum et al. 49 demonstrated an increase in resting energy expenditure after GBP surgery. In a prospective study, 70 severely obese patients were measured by indirect calorimetry before operation and at 6 weeks and 3, 6, 12, 18 and 24 months after operation. Using the HarrisBenedict equation on the basis of each patient's body weight, 50 patients were stratified to hypometabolic (resting energy expenditure o85% of Harris-Benedict predicted) or normal metabolic rate (resting energy expenditure ± 15%
Harris-Benedict predicted) before operation. Resting energy expenditure reduced over time in patients with a normal metabolic rate before surgery, whereas patients who were hypometabolic before GBP exhibited increases in their resting energy expenditure after the operation. 49 These changes occurred despite reduced energy intake comparable to a very low-calorie diet. The authors therefore concluded that this paradoxical effect on resting energy expenditure may contribute to the enhanced and maintained body weight loss associated with GBP surgery. 49 Major limitations that may account for discrepancies in the clinical studies outlined above include the heterogeneity of patient populations and energy expenditure measurements for a limited time using portable metabolic carts under artificial rather than 'free-living' conditions. Future clinical experiments should therefore include long-term measurements of energy expenditure over 24 h or even several days using respiration chambers that also allow an assessment of physical activity and diet-induced thermogenesis. 51 
Implications
The experimental and clinical data reviewed above, demonstrating an increase in energy expenditure after GBP, suggest that this operation significantly changes the physiological mechanisms by which the body regulates energy balance and body weight, respectively. These changes potentially explain why GBP is more effective and successful in maintaining long-term body weight loss than other means to induce weight loss, for example, dieting. Traditionally, body weight loss after GBP has been mainly attributed to mechanical reasons such as food restriction from reduced stomach size and nutrient malabsorption due to intestinal bypass. However, these mechanisms alone cannot explain the findings of the studies outlined above. An increased energy expenditure is incompatible with those mechanical means, because weight loss from dietary restriction normally leads to a decrease in energy expenditure aiming to conserve energy (starvation response). 42 The raised energy expenditure after GBP appears be specific for this intervention, as not all surgical manipulations of the gastrointestinal tract lead to increased energy expenditure; rats and humans with short bowel syndrome and associated malabsorption exhibit no change in total and/or resting energy expenditure. 52, 53 Moreover, measurements of energy expenditure in rat models of sleeve gastrectomy and gastric banding in which the only alteration is the reduction of stomach size revealed no significant effect on energy expenditure. 41, 54 Consequently, it seems that increased energy expenditure is associated with procedures that involve a rearranged gastrointestinal anatomy to cause duodenal exclusion from the alimentary flow or accelerated intestinal exposure to undigested nutrients (e.g., GBP).
Observations in animal models should not be translated into potential physiological effects in humans because of the anatomical and physiological differences of the gastrointestinal tract between humans and rodents. In fact, two major species differences between rats and humans regarding energy expenditure after GBP should be considered. First, gut hypertrophy in humans has been only described after a biliopancreatic diversion, but not after a standard proximal GBP. 55 Second, PYY and GLP-1 serum levels are elevated in rats in the fasting state, whereas humans display differences in PYY and GLP-1 levels only postprandially. 15 Nevertheless, rodent models have been proven to be extremely helpful to understand the pathophysiology of morbid obesity. 9, 15, 35, 41, 52 In conclusion, the available experimental and clinical data indicate that GBP surgery functions by altering the physiology of weight regulation and help explain the effectiveness of GBP in comparison with restrictive dieting and other forms of dietary and pharmacological therapies for obesity. The clinical effectiveness of GBP and its physiological effects on body weight regulation and energy expenditure suggest that this operation provides a unique opportunity to explore the mechanisms of energy homeostasis and identify novel therapies for obesity and related metabolic diseases.
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